Difference between revisions of "Part:BBa K2978000"

Line 3: Line 3:
 
<partinfo>BBa_K2978000 short</partinfo>
 
<partinfo>BBa_K2978000 short</partinfo>
  
This part makes references to an endolysin from a bacteriophage that infects <i>Clostridium difficile</i>. It is section of the complete protein CD27L, which in the residues 2 to 143 has its domain homologous to <i>N-acetyl-muramoyl-L-alanine</i>  amidases. In this part we synthesize  de novo the residues 1 to 179 of the protein, with codon optimization for <i>E.coli</i>. In previously works this reduced protein has shows a faster lysis to different strains of the pathogen and a high level of selectivity against clostridia [1].
+
This part makes references to an endolysin from a bacteriophage that infects <i>Clostridium difficile</i>. It is section of the complete protein CD27L, which in the residues 2 to 143 has its domain homologous to <i>N-acetyl-muramoyl-L-alanine</i>  amidases. In this part we synthesize  de novo the residues 1 to 179 of the protein, with codon optimization for <i>E.coli</i>. In previously works this reduced protein has shows a faster lysis to different strains of the pathogen and a high level of selectivity against clostridia (Wang, <i>et al.</i>; 2015).
  
 
 
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
 
+
The expression of this parts is under a T7 promoter, this mean that if we want to induce this protein we have to use a chassis with T7. In our case we confirm that <i>E. coli</i> BL21 de3 produce the lysin when IPTG is applied, because in this strain the polymerase is under a pLac promoter.
The expression of this parts is under a T7 promoter, this mean that if we want to induce this protein we have to use a chassis with T7. In our case we confirm that <i>E. coli</i> BL21 de3 produce the lysin when IPTG is applied, because in this strain the polymerase is under a pLac promoter (Figure 1).
+
 
+
===References===
+
 
+
Wang, Q., Euler, C. W., Delaune, A., & Fischetti, V. A. (2015). Using a Novel Lysin To Help Control <i>Clostridium difficile</i> Infections. Antimicrobial Agents and Chemotherapy, 59(12), 7447–7457. doi:10.1128/aac.01357-15
+
  
 
<!-- -->
 
<!-- -->

Revision as of 05:23, 10 October 2019


Causes cell lysis of the pathogen Clostridium difficile

This part makes references to an endolysin from a bacteriophage that infects Clostridium difficile. It is section of the complete protein CD27L, which in the residues 2 to 143 has its domain homologous to N-acetyl-muramoyl-L-alanine amidases. In this part we synthesize de novo the residues 1 to 179 of the protein, with codon optimization for E.coli. In previously works this reduced protein has shows a faster lysis to different strains of the pathogen and a high level of selectivity against clostridia (Wang, et al.; 2015).

Usage and Biology

The expression of this parts is under a T7 promoter, this mean that if we want to induce this protein we have to use a chassis with T7. In our case we confirm that E. coli BL21 de3 produce the lysin when IPTG is applied, because in this strain the polymerase is under a pLac promoter.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]